Patrick Donnelly
Stock Analyst at Citigroup
(3.83)
# 685
Out of 5,078 analysts
351
Total ratings
54.26%
Success rate
7.25%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $165 → $185 | $150.10 | +23.25% | 27 | Nov 25, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,468.09 | +15.80% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $321.50 | +16.64% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $329.36 | +13.86% | 17 | Oct 30, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $100 | $105.22 | -4.96% | 10 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $200 → $230 | $228.47 | +0.67% | 13 | Oct 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $580 | $585.15 | -0.88% | 20 | Oct 23, 2025 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $40 → $33 | $26.48 | +24.62% | 6 | Oct 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $179.71 | +11.29% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $63.79 | +9.74% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $26.05 | +61.23% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $47.86 | -20.60% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $176.09 | +13.58% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.84 | +6.89% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $128.72 | -37.85% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $18.08 | -17.04% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.75 | +53.19% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $183.77 | +0.67% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $224.14 | +18.23% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $12.44 | +84.89% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $17.35 | +15.27% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $101.20 | -25.89% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.58 | +24.00% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $102.43 | +41.56% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $47.34 | +30.54% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $397.79 | -24.58% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.41 | +273.44% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.08 | -10.71% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $267.73 | -2.89% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $9.68 | -38.02% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.06 | +353.26% | 2 | Nov 30, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $150.10
Upside: +23.25%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,468.09
Upside: +15.80%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $321.50
Upside: +16.64%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $329.36
Upside: +13.86%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $65 → $100
Current: $105.22
Upside: -4.96%
IQVIA Holdings
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $228.47
Upside: +0.67%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $580
Current: $585.15
Upside: -0.88%
QuidelOrtho
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $26.48
Upside: +24.62%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $179.71
Upside: +11.29%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $63.79
Upside: +9.74%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $26.05
Upside: +61.23%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $47.86
Upside: -20.60%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $176.09
Upside: +13.58%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.84
Upside: +6.89%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $128.72
Upside: -37.85%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $18.08
Upside: -17.04%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.75
Upside: +53.19%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $183.77
Upside: +0.67%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $224.14
Upside: +18.23%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $12.44
Upside: +84.89%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $17.35
Upside: +15.27%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $101.20
Upside: -25.89%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.58
Upside: +24.00%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $102.43
Upside: +41.56%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $47.34
Upside: +30.54%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $397.79
Upside: -24.58%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.41
Upside: +273.44%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.08
Upside: -10.71%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $267.73
Upside: -2.89%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $9.68
Upside: -38.02%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.06
Upside: +353.26%